Company: BWAY
Filing Date: 2025-09-30
Form Type: 6-K
Source: 0001171843-25-006185
Chunk: 10

Company: Brainsway Ltd.
Filing Date: 2025-09-30
Form: 6-K
Chunk 10
---
)

NOTE 5: CONTINGENT LIABILITIES, COMMITMENTS AND CHARGES

During the six months ended June 30, 2025, the Company repaid
approximately $600 in respect of refundable projects through royalties to the Israeli Government for participation grants in research
and development. During this period, no additional grants were received from the government of Israel.

NOTE 6: EQUITY

| a. | Composition of share capital: |

| Schedule of composition of share capital   |     |    June 30, 2025 |     |                        |     | December 31, 2024 |     |                        |
|:-------------------------------------------|:----|-----------------:|:----|-----------------------:|:----|------------------:|:----|-----------------------:|
|                                            |     |       Authorized |     | Issued and outstanding |     |        Authorized |     | Issued and outstanding |
|                                            |     | Number of shares |     |                        |     |                   |     |                        |
| Ordinary shares of NIS 0.04 par value each |     |      120,000,000 |     |             37,789,726 |     |       120,000,000 |     |             37,626,427 |

| b. | Movement in share capital: |

| Schedule of issued and outstanding capital |     |                  |     |               |
|                                            |     | Number of shares |     | NIS par value |
| Balance as of January 1, 2025              |     |       37,626,427 |     |     1,505,057 |
| Vesting of RSU                             |     |          148,761 |     |         5,950 |
| Exercise of share options                  |     |           14,538 |     |           582 |
| Balance as of June 30, 2025                |     |       37,789,726 |     |     1,511,589 |

NOTE 7: SHARE BASED PAYMENT

| a. | During the six months periods ended June 30, 2025 and 2024, the Company recorded expenses related to share-based 
 payment plans to employees, directors and consultants of $552 and $669, respectively.                            |

| b. | The following table presents the changes in the number and weighted average exercise prices of share options, 
 and the changes in the number of restricted shares